0000950123-20-001882.txt : 20200213 0000950123-20-001882.hdr.sgml : 20200213 20200213161620 ACCESSION NUMBER: 0000950123-20-001882 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200213 DATE AS OF CHANGE: 20200213 EFFECTIVENESS DATE: 20200213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VHCP Management III, LLC CENTRAL INDEX KEY: 0001738053 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18930 FILM NUMBER: 20610753 BUSINESS ADDRESS: STREET 1: 7 BRYANT PARK STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (650) 561-9580 MAIL ADDRESS: STREET 1: 7 BRYANT PARK STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001738053 XXXXXXXX 12-31-2019 12-31-2019 VHCP Management III, LLC

7 Bryant Park 23rd Floor New York NY 10018

13F HOLDINGS REPORT 028-18930 N David L. Stepp 650-561-9580 /s/ David L. Stepp Palo Alto CA 02-13-2020 0 18 503631 false INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F 10X Genomics Inc. COM 88025U109 22875 300000 SH SOLE 300000 0 0 89Bio Inc COM 282559103 25206 958765 SH SOLE 958765 0 0 Adverum Biotechnologies Inc COM 00773U108 10901 946234 SH SOLE 946234 0 0 Axsome Therapeutics Inc COM 05464T104 160001 1547994 SH SOLE 1547994 0 0 Bellerophon Therapeutics COM 078771102 134 383955 SH SOLE 383955 0 0 Constellation Pharmaceuticals COM 210373106 118540 2516242 SH SOLE 2516242 0 0 Forty Seven Inc COM 34983P104 20330 516381 SH SOLE 516381 0 0 Intra-Cellular Therapies Inc COM 46116X101 19728 575000 SH SOLE 575000 0 0 Iveric Bio Inc COM 46583P102 14584 1699797 SH SOLE 1699797 0 0 Kalvista Pharmaceuticals COM 483497103 11041 619905 SH SOLE 619905 0 0 Marinus Pharmaceuticals Inc COM 56854Q101 10835 5016164 SH SOLE 5016164 0 0 Mersana Therapeutics Inc COM 59045L106 8947 1561389 SH SOLE 1561389 0 0 Milestone Pharmaceuticals Inc COM 59935V107 33085 2066529 SH SOLE 2066529 0 0 Myovant Sciences Ltd COM G637AM102 7066 455255 SH SOLE 455255 0 0 Nextcure Inc COM 65343E108 6742 119693 SH SOLE 119693 0 0 Obseva SA COM H5861P103 3095 810264 SH SOLE 810264 0 0 Protagonist Therapeutics Inc COM 74366E102 571 80929 SH SOLE 80929 0 0 Relmada Therapeutics Inc COM 75955J402 29950 767938 SH SOLE 767938 0 0